2020 Homecare Personal care 
Hospice News
MAY 10, 2023
As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.
Hospice News
DECEMBER 2, 2024
Addus HomeCare Corporation (Nasdaq: ADUS) has closed its $350 million acquisition of Gentiva’s personal care business. Gentiva’s personal care segment brings in annual revenues of close to $280.0 Notably, we will now be the largest provider of personal care services in the state of Texas,” Allison said. “We
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
NOVEMBER 22, 2024
Valuations in the hospice space have led Addus Homecare (Nasdaq: ADUS) to take a more conservative approach to hospice transactions as it actively seeks home health and personal care deals. Hospice multiples reach record highs in 2020 and 2021, as much as 26x. Its personal care revenues reached $215.4
Hospice News
MARCH 8, 2023
High valuations have led Addus HomeCare (NASDAQ: ADUS) to pivot towards personal care and home health deals rather than hospice acquisitions. Hospice multiples broke records in 2020, 2021 and 2022, reaching as high as 29x. Addus began as a personal care provider in 1979. This is down from 51.6%
Hospice News
JANUARY 11, 2023
Ohio-based Queen City Hospice, an Addus Homecare (NASDAQ: ADUS) company, recently opened a new location in its home state. Queen City Hospice provides end-of-life care in six counties across the Cincinnati area in the southwest part of the state. Demographics are driving up a need for serious illness and end-of-life care in Ohio.
Hospice News
MARCH 3, 2023
billion divestiture of Kindred at Home’s hospice and personal care segments. As of 2020, Kindred at Home was the second-largest hospice provider in the United States by market share at 4.6%, according to LexisNexis. The deal marks Gentiva’s first purchase since the company emerged from Humana, Inc.’s s (NYSE: HUM) $2.8
Hospice News
DECEMBER 19, 2022
billion divestiture of a 60% stake in Kindred at Home’s hospice and personal care segments to the private equity firm Clayton, Dubilier & Rice. The move included six subsidiaries as well as Seasons Hospice & Palliative Care, which AccentCare merged with in Dec. Humana to Sell 60% of Kindred at Home Hospice to CDR for $2.8
Expert insights. Personalized for you.
246 
Let's personalize your content